Estimated SARS-CoV-2 Seroprevalence Among Persons Aged <18 Years — Mississippi, May–September 2020
- 5 March 2021
- journal article
- research article
- Published by Centers for Disease Control MMWR Office in Morbidity and Mortality Weekly Report (MMWR)
- Vol. 70 (9), 312-315
- https://doi.org/10.15585/mmwr.mm7009a4
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020JAMA Internal Medicine, 2021
- SARS-CoV-2 Positivity Rates Among Children of Racial and Ethnic Minority Groups in MississippiPEDIATRICS, 2021
- Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020JAMA Internal Medicine, 2020
- Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network — 12 States, April–August 2020Morbidity and Mortality Weekly Report (MMWR), 2020
- Estimated Incidence of Coronavirus Disease 2019 (COVID-19) Illness and Hospitalization—United States, February–September 2020Clinical Infectious Diseases, 2020
- Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, TennesseeJAMA, 2020
- Tuberculosis-related stigma among adults presenting for HIV testing in KwaZulu-Natal, South AfricaBMC Public Health, 2020
- Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreakNature Communications, 2020
- Estimated Community Seroprevalence of SARS-CoV-2 Antibodies — Two Georgia Counties, April 28–May 3, 2020Morbidity and Mortality Weekly Report (MMWR), 2020
- Interpreting Diagnostic Tests for SARS-CoV-2JAMA, 2020